Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: many pathways to neurodegeneration
about
Protein Recognition in Drug-Induced DNA Alkylation: When the Moonlight Protein GAPDH Meets S23906-1/DNA Minor Groove AdductsEnzyme-responsive nanomaterials for controlled drug deliveryDiabetes and Alzheimer disease, two overlapping pathologies with the same background: oxidative stressSubcellular dynamics of multifunctional protein regulation: mechanisms of GAPDH intracellular translocationAbeta, oxidative stress in Alzheimer disease: evidence based on proteomics studiesSex differences in brain proteomes of neuron-specific STAT3-null mice after cerebral ischemia/reperfusionSmart micro/nanoparticles in stimulus-responsive drug/gene delivery systems.Redox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: overlaps in Down's syndrome and Alzheimer's disease brain.Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.Pyruvate remediation of cell stress and genotoxicity induced by haloacetic acid drinking water disinfection by-products.Structural characterization of heparin-induced glyceraldehyde-3-phosphate dehydrogenase protofibrils preventing α-synuclein oligomeric species toxicityDietary methanol regulates human gene activityTestis-specific glyceraldehyde-3-phosphate dehydrogenase: origin and evolutionIncreased O-GlcNAc levels correlate with decreased O-GlcNAcase levels in Alzheimer disease brain.Global analysis of S-nitrosylation sites in the wild type (APP) transgenic mouse brain-clues for synaptic pathology.Validation of four reference genes for quantitative mRNA expression studies in a rat model of inflammatory injury.Oxidative stress in HPV-driven viral carcinogenesis: redox proteomics analysis of HPV-16 dysplastic and neoplastic tissues.Mitochondrial dysfunction and cellular metabolic deficiency in Alzheimer's diseaseA genome-wide detection of copy number variations using SNP genotyping arrays in swine.Proteomic analysis of lymphoblastoid cells from Nasu-Hakola patients: a step forward in our understanding of this neurodegenerative disorder.Cysteine-based redox switches in enzymesTime-dependent changes in gene expression induced by secreted amyloid precursor protein-alpha in the rat hippocampusFunctional divergence and convergent evolution in the plastid-targeted glyceraldehyde-3-phosphate dehydrogenases of diverse eukaryotic algaeQuantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer's disease subjects.4-hydroxy-2-nonenal-modified glyceraldehyde-3-phosphate dehydrogenase is degraded by cathepsin G in rat neutrophils.Diversity in autoimmunity against retinal, neuronal, and axonal antigens in acquired neuro-retinopathy.Protein S-nitrosylation: role for nitric oxide signaling in neuronal death.Interactions of glutathione transferases with 4-hydroxynonenal.Genetic variants in GAPDH confer susceptibility to sporadic Parkinson's disease in a Chinese Han population.Corticotropin-Releasing Factor Receptor-1 Antagonism Reduces Oxidative Damage in an Alzheimer’s Disease Transgenic Mouse Model.Characterization of the Cardiac Overexpression of HSPB2 Reveals Mitochondrial and Myogenic Roles Supported by a Cardiac HspB2 Interactome.Preconditioning with Ginkgo biloba (EGb 761®) provides neuroprotection through HO1 and CRMP2.Measurement of altered AβPP isoform expression in frontal cortex of patients with Alzheimer's disease by absolute quantification real-time PCRMitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stressEarly mitochondrial dysfunction leads to altered redox chemistry underlying pathogenesis of TPI deficiency.Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) phosphorylation by protein kinase Cδ (PKCδ) inhibits mitochondria elimination by lysosomal-like structures following ischemia and reoxygenation-induced injuryClinical implications from proteomic studies in neurodegenerative diseases: lessons from mitochondrial proteins.Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype.Lymphocyte mitochondria: toward identification of peripheral biomarkers in the progression of Alzheimer disease.Assessment of brain reference genes for RT-qPCR studies in neurodegenerative diseases.
P2860
Q26778143-5BEFD508-9C0C-4408-8BE7-B37D9C7268D8Q26992127-C7E621B3-805C-4F95-8F22-56C036D0352CQ27022552-7D4548CB-7519-4CDE-A7A2-84433F984C22Q27025760-5D8FFBC4-2058-4B18-9568-CAE08F5AD098Q27693922-9AF3F1CC-3EA8-454F-87B5-42C18331D28EQ28383413-55739CBB-FECF-4658-BE65-174A7ABC211DQ30361646-7AE9F6B2-9795-4049-98EE-D0753324CF72Q30367032-B33C4895-A78C-4572-B4A9-DCDD40B7CD91Q30446460-4B2D802B-6734-4FAE-97FF-1B69A0A70D25Q33583311-E3DD3714-F5CF-413D-BD08-E7FBEFB164E3Q33619357-6CC3B696-6184-4285-B2DE-FB650AAFEBD4Q33916628-85B6A99D-BEB9-4444-9E43-28B6FA623798Q33929601-2D43DEF6-E2CE-4992-A0F6-73955E29700BQ34073596-3056FBD5-0ECA-4109-B31F-DC33302EBA60Q34157658-52C5E162-BF4C-4586-91BD-8430227D445AQ34168961-8B0E0EEA-DD21-46DE-91A9-D06F450C2008Q34217919-95AEB627-2D3A-45BE-9D6C-CB3F14AACB53Q34299120-EF06784E-A4EF-4F57-B83D-99E14AF13D65Q34314872-380D1BE8-15E5-434A-ABDC-788268371FF8Q34623948-85BCC348-4DAD-4F48-A114-E7AC2CC2CE2FQ34722134-4EC60F4F-EBE7-4C0F-A9D8-909C0F7E2D77Q34761829-53CCF863-6E67-4D6E-80EC-CD6309E4176AQ34922766-487E5073-A2F5-4061-B42F-74BA3396A16CQ35059268-CA9F2A17-03DA-4BF5-AEB9-6E7D5AD3AAF7Q35195796-022E1384-B74C-44A5-9E08-DA7E82D19F5CQ35200446-2A466799-385E-4F6D-B32B-8CF7F3F1D6E2Q35653222-167609AC-62E0-4D8A-8542-1B8DAA5BEFD7Q35731685-B36CC2E7-D278-4B77-83E3-89E6D26FCB40Q35741353-3AE4EC2F-A70E-4086-BC2A-20237809B0B9Q35801845-D1911571-672B-4726-8B6B-2FC993102F4BQ35806089-5B8E88F8-3F40-4253-ACC2-3D259B71F654Q35823317-D566C952-E804-419F-B66C-1B66ADDF0A8BQ35886927-066E4221-E170-4709-B445-8151C2AEB1E1Q36767908-66FA311F-737E-41EC-A41C-581C89470305Q36773904-C351D359-2DFA-4C39-AC00-B6B04085FE89Q36967326-21C23CB9-C86C-4E3B-9DF3-3B5FCC7B7DE6Q37105161-BEED9BC9-6904-41A9-97DB-FDA3B7E459D7Q37141585-02791B53-4FC8-4115-A61E-298D82051627Q37361122-FCAEFD60-A65C-4286-A4B6-0E549F8396F2Q37419121-2DAA1F79-1E8F-4BF4-9576-E005F0013AC4
P2860
Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: many pathways to neurodegeneration
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Oxidatively modified glycerald ...... pathways to neurodegeneration
@ast
Oxidatively modified glycerald ...... pathways to neurodegeneration
@en
Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase
@nl
type
label
Oxidatively modified glycerald ...... pathways to neurodegeneration
@ast
Oxidatively modified glycerald ...... pathways to neurodegeneration
@en
Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase
@nl
prefLabel
Oxidatively modified glycerald ...... pathways to neurodegeneration
@ast
Oxidatively modified glycerald ...... pathways to neurodegeneration
@en
Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase
@nl
P2860
P356
P1476
Oxidatively modified glycerald ...... pathways to neurodegeneration
@en
P2093
Miranda L Bader Lange
Sarita S Hardas
P2860
P304
P356
10.3233/JAD-2010-1375
P577
2010-01-01T00:00:00Z